Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Bowers, Nathan L ^a   Helton, E Scott ^a   Huijbregts, Richard P H ^a   Goepfert, Paul A ^b,c   Heath, Sonya L ^b,c   Hel, Zdenek ^a,b,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ARGINASE 1; B7 ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD114 ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD209 ANTIGEN; CD247 PROTEIN; CD33 ANTIGEN; CD57 ANTIGEN; CD66B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEPTIDES AND PROTEINS; PROGRAM DEATH LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; NEUTROPHIL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS LOAD; VIRUS REPLICATION;

ANTIGENS, CD274; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE TOLERANCE; NEUTROPHILS; PROGRAMMED CELL DEATH 1 RECEPTOR; SIGNAL TRANSDUCTION;

EID: 84897470714     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003993     Document Type: Article

References (54)

1. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A, (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
2. Mantovani A, Cassatella MA, Costantini C, Jaillon S, (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519-531.
3. Chtanova T, Schaeffer M, Han S-J, van Dooren GG, Nollmann M, et al. (2008) Dynamics of Neutrophil Migration in Lymph Nodes during Infection. Immunity 29: 487-496.
4. Beauvillain C, Cunin P, Doni A, Scotet M, Jaillon S, et al. (2011) CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 117: 1196-1204.
5. Muller I, Munder M, Kropf P, Hansch GM, (2009) Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol 30: 522-530.
6. Pillay J, Tak T, Kamp VM, Koenderman L, (2013) Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: simil arities and differences. Cell Mol Life Sci.
7. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, et al. (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122: 327-336.
8. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. NatRevImmunol 9: 162-174.
9. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer research 69: 1553-1560.
10. Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, et al. (2012) Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer 130: 1109-1119.
11. Hel Z, McGhee JR, Mestecky J, (2006) HIV infection: first battle decides the war. Trends Immunol 27: 274-281.
12. Reuter MA, Pombo C, Betts MR, (2012) Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. Cytokine Growth Factor Rev 23: 181-191.
13. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
14. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
15. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720.
16. El-Far M, Halwani R, Said E, Trautmann L, Doroudchi M, et al. (2008) T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 5: 13-19.
17. Rosignoli G, Cranage A, Burton C, Nelson M, Steel A, et al. (2007) Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 21: 1379-1381.
18. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034.
19. Carter L, Fouser LA, Jussif J, Fitz L, Deng B, et al. (2002) PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32: 634-643.
20. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
21. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
22. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458: 206-210.
23. Dyavar Shetty R, Velu V, Titanji K, Bosinger SE, Freeman GJ, et al. (2012) PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. J Clin Invest 122: 1712-1716.
24. Finnefrock AC, Tang A, Li F, Freed DC, Feng M, et al. (2009) PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 182: 980-987.
25. Meier A, Bagchi A, Sidhu HK, Alter G, Suscovich TJ, et al. (2008) Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 22: 655-658.
26. Rodriguez-Garcia M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, et al. (2011) Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol 89: 507-515.
27. Vollbrecht T, Stirner R, Tufman A, Roider J, Huber RM, et al. (2012) Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26: F31-37.
28. Cloke T, Munder M, Bergin P, Herath S, Modolell M, et al. (2013) Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients. PLoS One 8: e72034.
29. Boasso A, Hardy AW, Landay AL, Martinson JL, Anderson SA, et al. (2008) PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol 129: 132-144.
30. Brenchley JM, Douek DC, (2012) Microbial translocation across the GI tract. Annu Rev Immunol 30: 149-173.
31. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. The Journal of infectious diseases 203: 780-790.
32. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, et al. (2011) Host Response to Translocated Microbial Products Predicts Outcomes of Patients with HBV or HCV infection. Gastroenterology 141: 1220-30.
33. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. NatMed 12: 1365-1371.
34. Worthen GS, Avdi N, Vukajlovich S, Tobias PS, (1992) Neutrophil adherence induced by lipopolysaccharide in vitro. Role of plasma component interaction with lipopolysaccharide. J Clin Invest 90: 2526-2535.
35. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, et al. (2004) Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoSBiol 2: E20.
36. Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, et al. (2006) Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J InfectDis 194: 29-37.
37. Cloke TE, Garvey L, Choi BS, Abebe T, Hailu A, et al. (2010) Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis 202: 374-385.
38. Munder M, (2009) Arginase: an emerging key player in the mammalian immune system. BrJPharmacol 158: 638-651.
39. Thewissen M, Damoiseaux J, van de Gaar J, Tervaert JWC, (2011) Neutrophils and T cells: Bidirectional effects and functional interferences. Molecular Immunology 48: 2094-2101.
40. Yamamoto S, Nava RG, Zhu J, Huang HJ, Ibrahim M, et al. (2012) Cutting edge: Pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils. J Immunol 189: 4221-4225.
41. de Kleijn S, Langereis JD, Leentjens J, Kox M, Netea MG, et al. (2013) IFN-gamma-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1. PLoS One 8: e72249.
42. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA, (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15: 496-497.
43. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, et al. (2009) Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 183: 7441-7450.
44. Fujisawa H, (2008) Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 82: 2772-2783.
45. McNab FW, Berry MP, Graham CM, Bloch SA, Oni T, et al. (2011) Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur J Immunol 41: 1941-1947.
46. Cloke T, Munder M, Taylor G, Muller I, Kropf P, (2012) Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS One 7: e48939.
47. Rodriguez PC, Quiceno DG, Ochoa AC, (2007) L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109: 1568-1573.
48. Buckley CD, Ross EA, McGettrick HM, Osborne CE, Haworth O, et al. (2006) Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 79: 303-311.
49. Kaplan MJ, Radic M, (2012) Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol 189: 2689-2695.
50. Kropf P, Baud D, Marshall SE, Munder M, Mosley A, et al. (2007) Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 37: 935-945.
51. Prince LR, Whyte MK, Sabroe I, Parker LC, (2011) The role of TLRs in neutrophil activation. Curr Opin Pharmacol 11: 397-403.
52. Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Kruhlak MJ, et al. (2006) Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc Natl Acad Sci U S A 103: 7000-7005.
53. von Sydow M, Sonnerborg A, Gaines H, Strannegard O, (1991) Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 7: 375-380.
54. Shadduck PP, Weinberg JB, Haney AF, Bartlett JA, Langlois AJ, et al. (1991) Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. J Virol 65: 4309-4316.